201 related articles for article (PubMed ID: 3882999)
1. The role of hemodynamic factors in the initiation and progression of renal disease.
Anderson S; Meyer TW; Brenner BM
J Urol; 1985 Mar; 133(3):363-8. PubMed ID: 3882999
[No Abstract] [Full Text] [Related]
2. Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction.
Hostetter TH; Rennke HG; Brenner BM
Am J Kidney Dis; 1982 Mar; 1(5):310-4. PubMed ID: 7072714
[No Abstract] [Full Text] [Related]
3. Anemia: a potent modulator of renal hemodynamics in models of progressive renal disease.
Lafferty HM; Anderson S; Brenner BM
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):2-7. PubMed ID: 2024667
[No Abstract] [Full Text] [Related]
4. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
Brenner BM; Meyer TW; Hostetter TH
N Engl J Med; 1982 Sep; 307(11):652-9. PubMed ID: 7050706
[No Abstract] [Full Text] [Related]
5. Progression of renal disease and renal hypertrophy.
Hostetter TH
Annu Rev Physiol; 1995; 57():263-78. PubMed ID: 7778868
[No Abstract] [Full Text] [Related]
6. Effect of familial hypertension on glomerular hemodynamics and tubulo-glomerular feedback after uninephrectomy.
Guidi E; Cozzi MG; Minetti EE; Civati G; Busnach G; Brando B
Am J Hypertens; 2001 Feb; 14(2):121-8. PubMed ID: 11243302
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
Fujihara CK; Antunes GR; Mattar AL; Andreoli N; Malheiros DM; Noronha IL; Zatz R
Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
[TBL] [Abstract][Full Text] [Related]
8. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
Kriz W; LeHir M
Kidney Int; 2005 Feb; 67(2):404-19. PubMed ID: 15673288
[TBL] [Abstract][Full Text] [Related]
9. Glomerular response to renal injury.
Brenner BM; Goldszer RC; Hostetter TH
Contrib Nephrol; 1982; 33():48-66. PubMed ID: 6749423
[No Abstract] [Full Text] [Related]
10. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
Hostetter TH
Semin Nephrol; 1990 May; 10(3):219-27. PubMed ID: 2190279
[No Abstract] [Full Text] [Related]
11. Impact of antihypertensive therapy on progressive kidney damage.
Dworkin LD; Benstein JA
Am J Hypertens; 1989 Jun; 2(6 Pt 2):162S-172S. PubMed ID: 2665787
[TBL] [Abstract][Full Text] [Related]
12. [Function of the kidney in some of its diseases in pregnancy].
Shekhtman MM
Urol Nefrol (Mosk); 1974; (3):25-8. PubMed ID: 4446163
[No Abstract] [Full Text] [Related]
13. Cyclosporine: glomerular hemodynamics.
Barros EJ; Boim MA; Figueiredo JF; Sigulem D; Ramos OL; Schor N
Transplant Proc; 1987 Feb; 19(1 Pt 2):1754. PubMed ID: 3274420
[No Abstract] [Full Text] [Related]
14. Progressive renal disease: is the slippery slope species specific?
Hostetter TH
J Lab Clin Med; 1987 Apr; 109(4):375-7. PubMed ID: 3819574
[No Abstract] [Full Text] [Related]
15. Glomerular normalcy and pathosis: a "fin de millénaire" perspective.
Nadim MK; Brenner BM
J Nephrol; 1999; 12 Suppl 2():S16-28. PubMed ID: 10688399
[No Abstract] [Full Text] [Related]
16. Filtration surface area, salt intake and hypertension.
Brenner BM; Anderson S
Contrib Nephrol; 1989; 75():45-59. PubMed ID: 2697507
[No Abstract] [Full Text] [Related]
17. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
[TBL] [Abstract][Full Text] [Related]
18. Research seminar: physiology of acute renal failure.
Kon V; Ichikawa I
J Pediatr; 1984 Sep; 105(3):351-7. PubMed ID: 6381678
[No Abstract] [Full Text] [Related]
19. On the natural tendency to progressive loss of remaining kidney function in patients with impaired renal function.
Hebert LA; Bay WH
Med Clin North Am; 1990 Jul; 74(4):1011-24. PubMed ID: 2195255
[TBL] [Abstract][Full Text] [Related]
20. Nephrectomy modifies renal angiotensin II effects in kidney donors.
Guidi E; Cozzi M; Milani S; Spada E
Am J Hypertens; 2008 May; 21(5):592-8. PubMed ID: 18437153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
